142 related articles for article (PubMed ID: 9358532)
1. Is heparin therapy necessary in CAPD peritonitis?
Nadig C; Binswanger U; von Felten A
Perit Dial Int; 1997; 17(5):493-6. PubMed ID: 9358532
[TBL] [Abstract][Full Text] [Related]
2. Coagulation- and fibrinolysis-related antigens in plasma and dialysate of CAPD patients.
Goedde M; Sitter T; Schiffl H; Bechtel U; Schramm W; Spannagl M
Perit Dial Int; 1997; 17(2):162-6. PubMed ID: 9159837
[TBL] [Abstract][Full Text] [Related]
3. Is interleukin-6 concentration in the dialysate of continuous ambulatory peritoneal dialysis patients a prognostic parameter in peritonitis?
Fiedler R; Schneider I; Fischer K; Deuber HJ; Osten B
Adv Perit Dial; 2001; 17():159-62. PubMed ID: 11510267
[TBL] [Abstract][Full Text] [Related]
4. Imbalance between intraperitoneal coagulation and fibrinolysis during peritonitis of CAPD patients: the role of mesothelial cells.
Sitter T; Spannagl M; Schiffl H; Held E; van Hinsbergh VW; Kooistra T
Nephrol Dial Transplant; 1995; 10(5):677-83. PubMed ID: 7566582
[TBL] [Abstract][Full Text] [Related]
5. Relation of intraperitoneal and intravascular coagulation and fibrinolysis related antigens in peritoneal dialysis.
Gries E; Kopp J; Thomae U; Kuhlmann H
Thromb Haemost; 1990 Jun; 63(3):356-60. PubMed ID: 2205948
[TBL] [Abstract][Full Text] [Related]
6. Nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis.
Choi KC; Jeong TK; Lee SC; Kim SW; Kim NH; Lee KY
Adv Perit Dial; 1998; 14():173-9. PubMed ID: 10649719
[TBL] [Abstract][Full Text] [Related]
7. Intraperitoneal fibrin-formation and its inhibition in CAPD.
Gries E; Paar D; Graben N; Bock KD
Clin Nephrol; 1986 Oct; 26(4):209-12. PubMed ID: 3780071
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of intraperitoneal cefazolin and gentamicin in empiric therapy of peritonitis in continuous ambulatory peritoneal dialysis patients.
Tosukhowong T; Eiam-Ong S; Thamutok K; Wittayalertpanya S; Na Ayudhya DP
Perit Dial Int; 2001; 21(6):587-94. PubMed ID: 11783768
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of clindamycin in the plasma and dialysate after intraperitoneal administration of clindamycin phosphoester to patients on continuous ambulatory peritoneal dialysis: an open-label, prospective, single-dose, two-institution study.
Chang MJ; Namgung H; Choi HD; Song YR; Kim SG; Oh JM; Shin WG
Basic Clin Pharmacol Toxicol; 2012 Jun; 110(6):504-9. PubMed ID: 22151828
[TBL] [Abstract][Full Text] [Related]
10. Lipid-related hemostatic abnormalities in the elderly: imbalance between coagulation and fibrinolysis.
Kario K; Matsuo T
Atherosclerosis; 1993 Nov; 103(2):131-8. PubMed ID: 8292090
[TBL] [Abstract][Full Text] [Related]
11. Plasminogen activator inhibitor-1 4G/5G genetic polymorphism does not affect peritoneal transport characteristic.
Szeto CC; Poon P; Szeto CY; Wong TY; Lai KB; Li PK
Am J Kidney Dis; 2002 May; 39(5):1061-7. PubMed ID: 11979351
[TBL] [Abstract][Full Text] [Related]
12. Intraperitoneal interleukin-8 and neutrophil influx in the initial phase of a CAPD peritonitis.
Betjes MG; Visser CE; Zemel D; Tuk CW; Struijk DG; Krediet RT; Arisz L; Beelen RH
Perit Dial Int; 1996; 16(4):385-92. PubMed ID: 8863332
[TBL] [Abstract][Full Text] [Related]
13. Increase in the D-dimer levels during treatment in patients with acute myelogenous leukemia.
Velasco F; Torres A; Rojas R; Alvarez MA; Gomez P; Castillo D
Haemostasis; 1992; 22(3):117-23. PubMed ID: 1427455
[TBL] [Abstract][Full Text] [Related]
14. Coagulation and fibrinolysis factors in dialysis patients with and without ischemic heart disease.
Oda H; Ohno M; Ohashi H
Adv Perit Dial; 2000; 16():152-5. PubMed ID: 11045282
[TBL] [Abstract][Full Text] [Related]
15. Effect of intraperitoneal administration of heparin to patients on continuous ambulatory peritoneal dialysis (CAPD).
Takahashi S; Shimada A; Okada K; Kuno T; Nagura Y; Hatano M
Perit Dial Int; 1991; 11(1):81-3. PubMed ID: 2049431
[TBL] [Abstract][Full Text] [Related]
16. Time course of hemostatic abnormalities in sepsis and its relation to outcome.
Lorente JA; García-Frade LJ; Landín L; de Pablo R; Torrado C; Renes E; García-Avello A
Chest; 1993 May; 103(5):1536-42. PubMed ID: 8486040
[TBL] [Abstract][Full Text] [Related]
17. Tissue-type plasminogen activator (tPA) and its inhibitor (PAI-1) in patients treated with continuous ambulatory peritoneal dialysis.
Opatrný K; Opatrná S; Vít L; Opatrný K
Am J Nephrol; 1998; 18(3):186-92. PubMed ID: 9627033
[TBL] [Abstract][Full Text] [Related]
18. High F1.2 fragment of prothrombin, thrombin-antithrombin III complex (TAT) and soluble fibrin plasma levels demonstrate hypercoagulability induced during loco-regional thrombolytic therapy with rt-PA.
Garcia-Avello A; Garcia-Frade LJ; Gandarias C; Ocaña J; Cancelas JA; Lasso M
Thromb Res; 1994 Jan; 73(2):109-15. PubMed ID: 8171409
[TBL] [Abstract][Full Text] [Related]
19. Intraperitoneal hypercoagulation and hypofibrinolysis is present in childhood peritonitis.
de Boer AW; Levi M; Reddingius RE; Willems JL; van den Bosch S; Schröder CH; Monnens LA
Pediatr Nephrol; 1999 May; 13(4):284-7. PubMed ID: 10454774
[TBL] [Abstract][Full Text] [Related]
20. Plasma levels of total plasminogen activator inhibitor-I (PAI-I) and tPA/PAI-1 complex in patients with disseminated intravascular coagulation and thrombotic thrombocytopenic purpura.
Watanabe R; Wada H; Miura Y; Murata Y; Watanabe Y; Sakakura M; Okugawa Y; Nakasaki T; Mori Y; Nishikawa M; Gabazza EC; Shiku H; Nobori T
Clin Appl Thromb Hemost; 2001 Jul; 7(3):229-33. PubMed ID: 11441985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
